Oric Pharmaceuticals Inc is a high-risk ESG focused pharmaceutical company in the United States. Specializing in hormone-dependent cancers, precision oncology, and key tumor dependencies, Oric has a pipeline of therapies to combat resistance mechanisms in cancer. With product candidates like ORIC-944, ORIC-114, and ORIC-533, Oric Pharmaceuticals is dedicated to creating sustainable solutions for the environment and governance.